Antigen-Specific Immune Tolerance Drug Development Meeting – Boston, MA
With Dr. Patricia Bettinger, the Scientific Director of EpiVax’s Tregitope program, I will be attending the 3rd Annual Antigen-Specific Immune Tolerance Drug Development meeting in Boston, MA from February 25-27, 2020.

EpiVax is happy to be offering it’s loyal newsletter readers 10% off registration.  Use code: EPIVAX10 during registration to receive the promotional rate. We hope to see you there!

If you will be in Boston for the meeting, please stop by the session and say hello, or reach out to info@epivax.com to schedule a meeting with me!